Found 1 document(s)
Page 1 of 1
-
The role of metabolic syndrome (MetS) in prostate cancer risk is still debated. We investigated it in a large population-based case-control study. Cases were 1937 men with incident prostate cancer, aged ≤ 75 years, diagn...